In a memo to Dr Walford, Mr Wrigglesworth (DHSS) queried whether further action was required on pre-March 1983 blood products as such products continued to be used in the USA.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Diana Walford